Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

NCT: NCT06777368 · RECRUITING

NCT IDNCT06777368
StatusRECRUITING
Start Date2025-02-06
SponsorMedtronic Cardiovascular (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑